Ling Lu
Impact in
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Atherosclerosis and Cardiovascular Diseases 3
-
- Asthma and respiratory diseases 4
- Co-authors
- Gigi N.C. Chiu (1 shared paper)Hao Daniel Lin (1 shared paper)Pengyuan Yang (5 shared papers)Yao‐Cheng Rui (5 shared papers)Hui Kang (3 shared papers)Tiejun Li (3 shared papers)Zhengwei Zhang (1 shared paper)Di Qi (1 shared paper)
In The Last Decade
Ling Lu
15 papers receiving 366 citations
Peers
Comparison fields: 5 of 68
- Drug Discovery 1
- Complementary and alternative medicine 32
- Geriatrics and Gerontology 9
- Immunology 34
- Cancer Research 22
Countries citing papers authored by Ling Lu
This map shows the geographic impact of Ling Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lu more than expected).
Fields of papers citing papers by Ling Lu
This network shows the impact of papers produced by Ling Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lu. The network helps show where Ling Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 129 | |
| 2 | 2005 | 56 | |
| 3 | 2018 | 40 | |
| 4 | 2007 | 28 | |
| 5 | 2021 | 24 | |
| 6 | 2009 | 20 | |
| 7 | 2006 | 17 | |
| 8 | 2018 | 17 | |
| 9 | 2005 | 11 | |
| 10 | 2024 | 10 | |
| 11 | 2014 | 7 | |
| 12 | 2021 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2019 | 3 | |
| 15 | 2020 | 3 |
About Ling Lu
Ling Lu is a scholar working on Immunology, Physiology, Epidemiology, Cardiology and Cardiovascular Medicine and Rehabilitation, having authored 15 papers that have together received 374 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (4 papers), Atherosclerosis and Cardiovascular Diseases (3 papers), Cholesterol and Lipid Metabolism (1 paper), Magnolia and Illicium research (1 paper), Acute Ischemic Stroke Management (1 paper), COVID-19 Clinical Research Studies (1 paper), Liver Disease Diagnosis and Treatment (1 paper) and Autophagy in Disease and Therapy (1 paper). The work is most often cited by research in Drug Discovery (1 citation), Complementary and alternative medicine (32 citations), Geriatrics and Gerontology (9 citations), Immunology (34 citations) and Cancer Research (22 citations). Ling Lu has collaborated with scholars based in China and Singapore. Frequent co-authors include Gigi N.C. Chiu, Hao Daniel Lin, Pengyuan Yang, Yao‐Cheng Rui, Hui Kang, Tiejun Li, Zhengwei Zhang, Di Qi, Daoxin Wang and Lan Chen. Their work appears in journals such as Life Sciences, Journal of Pharmacological Sciences, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, iScience and Journal of Magnetic Resonance Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.